Emergent Biosolutions Inc. buy Quitte
Start price
18.12.17
/
50%
€41.75
Target price
08.03.18
€46.90
Performance (%)
12.99%
End price
08.03.18
€47.18
Summary
This prediction ended on 08.03.18 with a price of €47.18. The BUY prediction by Quitte finished with a performance of 12.99%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Emergent Biosolutions Inc. | 1.615% | 1.615% | 23.161% | -0.954% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by Quitte for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
langsam, aber stetig
aufwärts.
Außerdem eine Zacks-Empfehlung - denen ich jedoch nicht blind zu folgen gedenke, wie z.B. bei Peregrine, die mit Zacks#4 bewertet wird.
Hier überzeugt mich der Chart.